VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,438,000 | +4.8% | 153,200 | +36.8% | 0.04% | +23.5% |
| Q4 2017 | $2,327,000 | +282.1% | 112,000 | +166.7% | 0.03% | +126.7% |
| Q4 2016 | $609,000 | -82.8% | 42,000 | -70.9% | 0.02% | -87.2% |
| Q3 2016 | $3,547,000 | -78.1% | 144,500 | -82.0% | 0.12% | -84.5% |
| Q2 2016 | $16,186,000 | -37.3% | 803,700 | -18.1% | 0.76% | -39.5% |
| Q1 2016 | $25,823,000 | +199.6% | 981,900 | +2162.4% | 1.25% | +50.7% |
| Q1 2015 | $8,620,000 | +452.9% | 43,400 | +298.2% | 0.83% | +245.0% |
| Q4 2014 | $1,559,000 | -32.9% | 10,900 | -38.4% | 0.24% | -46.4% |
| Q3 2014 | $2,322,000 | +40.3% | 17,700 | +25.5% | 0.45% | +181.8% |
| Q4 2013 | $1,655,000 | – | 14,100 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |